Jérôme Kluza

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

David Devos, Caroline Moreau, Jean Christophe Devedjian et al. · Antioxidants and Redox Signaling · 2013 · 613 citations · Full text

Medicine, Neurology, Pharmacology +17

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Mohamed Trabelsi, Mehdi Daoudi, Janne Prawitt et al. · Nature Communications · 2015 · 379 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells

Jérôme Kluza, Philippe Marchetti, Miguel-Angel Gallego et al. · Oncogene · 2004 · 180 citations

Life Sciences, Oncology, Pharmacology +16

Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor

Paola Corazao-Rozas, P. Guerreschi, Manel Jendoubi et al. · Oncotarget · 2013 · 176 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Cancer Cell Mitochondria Are Direct Proapoptotic Targets for the Marine Antitumor Drug Lamellarin D

Jérôme Kluza, Miguel-Angel Gallego, Anne Loyens et al. · Cancer Research · 2006 · 161 citations

Life Sciences, Cell Biology, Pharmacology +17